Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Episurf Medical ABLTS:0QUT -2.42% Buyback Yield % is -3.38 as of Jul. 24, 2026. The stock has 7 warning signs investors should review. Among 349 Medical Devices & Instruments companies, Episurf Medical AB ranks worse than 60.74% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
Episurf Medical AB Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Episurf Medical AB's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0QUT vs ABT, SYK, MDT: Buyback Yield % Comparison
For the Medical Devices subindustry, Episurf Medical AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Episurf Medical AB Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Episurf Medical AB's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Episurf Medical AB's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Episurf Medical AB (LTS:0QUT) has a Buyback Yield % of -3.38 as of Jul. 24, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Episurf Medical AB and its competitors. According to the industry distribution chart, Episurf Medical AB ranks #212 out of 349 companies in the Medical Devices & Instruments industry, placing it in the top 60.7%.
Is Episurf Medical AB's Buyback Yield % too high?
Episurf Medical AB's current Buyback Yield % is -3.38. Based on the distribution chart, Episurf Medical AB ranks #212 out of 349 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Episurf Medical AB's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Episurf Medical AB ranks #212 out of 349 companies for Buyback Yield %. This places Episurf Medical AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Episurf Medical AB and its competitors. Episurf Medical AB's current Buyback Yield % is -3.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Episurf Medical AB stock overvalued right now?
Based on GuruFocus' analysis, Episurf Medical AB (LTS:0QUT) is currently considered Modestly Overvalued. The stock's GF Value™ is kr0.05, compared to a current price of kr0.06 — trading 13% above its estimated fair value. The current Buyback Yield % is -3.38. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Episurf Medical AB (LTS:0QUT), the current Buyback Yield % is -3.38 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint. The company is forming a new strategic business segment through the acquisition of real estate assets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QUT has been successfully added to your 
